ArticleJapanese journal of clinical oncology2022

Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up.

Hiroki Ishihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.